trié(s) par (Pertinence décroissant(e), Titre croissant(e)) 

Article

Efficacy and safety of hypofractionated stereotactic radiotherapy for brain metastases using three fractions: A single-centre retrospective study

E. Vigneau ; J. Jacquemin ; B. Benadon ; T. Dat Nguyen ; C. Marchand-Créty |

Dans Cancer/Radiothérapie (vol. 25, no. 8, Décembre 2021)

/Purpose Hypofractionated stereotactic radiotherapy (HFSRT) has become a standard of care for patients with a limited number of brain metastases (BM). An increasing number of linear accelerators (LA) are able to accurately perform HFSRT includ[...]

Plus d'information... En ligne

Article

Impact of radiotherapy on survival in resected or unresectable anaplastic thyroid carcinomas, a Rare Cancer Network study

X.S. Sun ; J. Le Guevelou ; J. Jacquemin ; Y. Drouet ; T.S. Sio ; G. Bar-Sela ; C. Carrie ; J.-C. Faivre ; J. Khalifa ; C. Demiroz ; H. Qiu ; U. Schick ; B. Atalar ; N. Fakhry ; L. Mengue ; J. Pan ; S. Servagi-Vernat ; J. Thariat |

Dans Cancer/Radiothérapie (vol. 26, no. 5, Septembre 2022)

Purpose Anaplastic thyroid carcinomas (ATC) are a heterogenous group of tumors of overall dismal prognosis. We designed models to identify relevant prognostic factors of survival of irradiated ATC patients including radiotherapy modalities (fiel[...]

Plus d'information... En ligne